文章摘要
黄茹燕,徐 曙,方 群,武 欣,关承斌,乔慧芬,李箕君.首发抑郁症患者西酞普兰治疗前后血清神经肽与细胞因子水平研究[J].南京医科大学学报,2014,(5):641~644
首发抑郁症患者西酞普兰治疗前后血清神经肽与细胞因子水平研究
The changes of serum levels of neuropeptide and cytokines before and after citalopram treatment in the depressive patients with the first episode
投稿时间:2014-01-23  
DOI:10.7655/NYDXBNS20140521
中文关键词: 抑郁症  神经肽类递质  细胞因子
英文关键词: depression  neuropeptide  cytokines
基金项目:南京医科大学科技发展基金资助(07NMUM035)
作者单位
黄茹燕 南京医科大学附属脑科医院医学心理科,江苏 南京 210029 
徐 曙 南京医科大学附属脑科医院医学心理科,江苏 南京 210029 
方 群 南京医科大学附属脑科医院研究所,江苏 南京 210029 
武 欣 南京医科大学附属脑科医院医学心理科,江苏 南京 210029 
关承斌 南京医科大学附属脑科医院医学心理科,江苏 南京 210029 
乔慧芬 南京医科大学附属脑科医院医学心理科,江苏 南京 210029 
李箕君 南京医科大学附属脑科医院医学心理科,江苏 南京 210029 
摘要点击次数: 826
全文下载次数: 546
中文摘要:
      目的:探讨首发抑郁症患者西酞普兰治疗前后血清神经肽与细胞因子水平的变化?方法:采用放射免疫分析法检测50例首发未用药抑郁症患者西酞普兰治疗前后和40例健康对照组血清神经肽[神经肽Y(NPY)?β-内啡肽(β-EP)?胃动素(MTL)]和细胞因子[肿瘤坏死因子α(TNF-α)?胰岛素生长因子-Ⅱ(IGF-Ⅱ)]水平,用汉密尔顿抑郁量表(HAMD-17)?汉密尔顿焦虑量表(HAMA)评估情感症状和疗效,并进行统计分析?结果:首发抑郁症患者治疗前血清β-EP(340.31 ± 94.97)pg/ml?TNF-α(14.64 ± 9.23)ng/ml和IGF-II(0.80 ± 0.30)ng/ml水平较对照组均显著增高(均P < 0.05),血清NPY(96.41 ± 32.98)pg/ml水平显著低于对照组(P < 0.05),药物治疗后IGF-II降低(P < 0.05),NPY增加(P < 0.05)?回归分析发现NPY是抑郁症的独立影响因素(P = 0.012),MTL治疗前后的差值与药物疗效相关(P = 0.016)?结论:首发抑郁症患者神经肽和细胞因子存在异常,低水平NPY可能是抑郁症的特征性指标,MTL水平上升可能预测疗效?
英文摘要:
      Objective:To compare the serum levels of neuropeptide and cytokines in first episode depressive patients before and after citalopram treatment. Methods:The serum levels of neuropeptide[neuropeptide Y (NPY),β-endorphin (β-EP) and Motilin (MTL)]and cytokines[tumor necrosis factor α(TNF-α) and insulin-like growth factorsⅡ(IGF-Ⅱ)] were measured using radioimmunoassay in 50 first-episode drug-naive depressive patients before and after antidepressant treatment and 40 healthy controls. Severity of depression and treatment efficacy were assessed according to the Hamilton Depression Scale (HAMD-17) and Hamilton Anxiety Scale (HAMA),and analyzed with the SPSS17.0 statistical package. Results:The serum levels of β-EP (340.31 ± 94.97 pg/ml),TNF-α(14.64 ± 9.23 ng/ml) and IGF-II (0.80 ± 0.30 ng/ml) were significantly higher in first-episode drug-naive depression patients than controls (all P < 0.0001),and serum levels of NPY (96.41 ± 32.98 pg/ml) in depressive patients were significantly lower than control group (P < 0.0001). The serum levels of IGF-II reduced (P < 0.0001) after 6-week of therapy,while NPY increased (P < 0.05). Regression analysis showed that the serum NPY was the important risk factor of depressive (P = 0.012),and the change of MTL was the association factor influencing the therapeutic effect (P = 0.016). Conclusion:The change of serum neuropeptide and cytokines may be involved in pathophysiology of the first episode depressive patients. The low serum NPY may be a potential predictive index for the depressive episode,while the increase of MTL can predict the antidepressant efficacy.
查看全文   查看/发表评论  下载PDF阅读器
关闭